Posts with #mRNA

#mRNA

Public posts on X that use #mRNA.

Related hashtags

  1. Adam May✓@A_May_MD
    $MRNA with the single most hilarious possible outcome in this study. EFS HR 0.58. Down the the hundredth, EXACTLY what *NEO*-adjuvant treatment with pembro yielded against adjuvant pembro (the nerfed comparator $MRNA studied against) in SWOG S1801. What does this mean in English? $MRNA’s drug is showing the exact same benefit versus adjuvant pembrolizumab as NEOadjuvant pembrolizumab did. Even more simply? If you just give patients a few doses of the pembrolizumab BEFORE you cut their cancer out, you do what $MRNA does for you, except with just the free tumor that’s already inside your body. No need to pay for this $400K drug. And this makes rational sense, right? The whole point of $MRNA’s vaccine is to produce stuff that looks like the tumor. You know what looks A LOT like the tumor does? THE FREAKING TUMOR!!!!!! Absolutely poetic that $MRNA produced the EXACT HR benefit as neoadjuvant pembro did. Truly, the most hilarious possible outcome. Now can we move on from this bullshit? $MRK and $MRNA should feel free to study their vaccine against the REAL standard of care now - NEOadjuvant immunotherapy. From my perspective, this has been total fugaze, and an amateurish pump and dump worthy of much lesser enterprises.
    Download
    8084584227K
  2. Peter A. McCullough, MD, MPH®✓@P_McCulloughMD
    This wave of #mRNA myocarditis is probably just the tip of the iceberg. I am very concerned about sub-clinical cases presenting with cardiac arrest two years after the shots. Rose data alone should have had these black-boxed and off market.
    831.4K3.2K130K
  3. Klebanoff_Lab@KlebanoffLab
    👉Another important reminder that immunogenicity can be uncoupled from clinical benefit. #MRNA's adjuvant pancreatic cancer vaccine data: 100% of patients developed T cell responses against >/=1 vaccine-encoded predicted neoantigens *yet* 45% developed short term relapse.
    Download
    17362.7K
  4. Maik Pittel✓@maikpi70
    #Impfung #Shedding Eilmeldung: Neue Arbeit zeigt, wie #mRNA-Impfstoffmaterialien von Geimpften auf Ungeimpfte übergehen könnten
    24501134.9K
  5. Maik Pittel✓@maikpi70
    #Impfung Der ehemalige Vizepräsident von #Pfizer, Dr. Mike Yeadon, lässt eine Bombe platzen und behauptet, dass die #mRNA-#COVID-"#Impfstoffe" absichtlich entwickelt wurden, um zu schaden, zu behindern und zu töten, mit dem Ziel, die menschliche Fruchtbarkeit zu verringern.‼️
    Download
    2291.6K4.5K260K
  6. DR JANE RUBY™️✓@RealDrJaneRuby
    Stop and think They want you to believe that the material that caused an 1100% increase in cancer is now going to cure it...with no proof (Lymphoma patient 2 wks after his Pfizer booster, black areas show cancer activity) #mRNA
    Download
    1441.3K2.4K105K
  7. PAX✓@paxresearch
    $MRNA crashed -25% today, its worst day ever, after its personalized cancer vaccine data with Merck leaked online. Wild part: the data was GOOD — 42% lower recurrence-or-death risk — pure sell-the-news after a 500%+ YTD run 😬 #MRNA #Biotech #BreakingNews
    Download
    60122.4K
  8. Tom Renz✓@RenzTom
    The #NIAA has been sharing this misinformation/outright lie with elected officials & farmers. Understand #mRNA CAN be legally used in ORGANIC labeled food under current guidelines. Also know they are lying about mRNA which is almost always lab modified to #modRNA ) both start with m). Also know that the world’s largest seed producer Bayer Monsanto has partnered with Pfizer BioNTech. Truth hurts for the #WEF crooks. @P_McCulloughMD @VigilantFox @TheChiefNerd @KanekoaTheGreat @GenFlynn @HISGLORYME @BusyDrT @NeputeWellness @DrJudyAMikovits @MelKShow @Jim_Jordan @RandPaul @floydbrown @Leon4Congress @lancewallnau @joerogan @TuckerCarlson
    Download
    651.1K1.5K142K
  9. Polymarket Money✓@PolymarketMoney
    JUST IN: Moderna and Merck reveal their personalized mRNA cancer vaccine “succeeded in Phase 3” slowing melanoma recurrence and spread with Keytruda.
    91622115.6K
  10. Moderna✓@moderna_tx
    Today we announced detailed positive results from the Phase 3 INTerpath-001 study evaluating intismeran autogene (mRNA-4157 or V940), an investigational mRNA-based individualized neoantigen therapy, in combination with KEYTRUDA® (pembrolizumab), @Merck's anti-PD-1 therapy, in patients with high-risk melanoma (stage IIB-IV) following complete resection. These late-breaking results will be presented during a Presidential Symposium at the 2026 European Society for Medical Oncology (@myESMO) Congress. Read more:
    Download
    04323143.1K
  11. Moderna✓@moderna_tx
    Today we announced that three abstracts on intismeran autogene, our investigational mRNA-based individualized neoantigen therapy, have been accepted for presentation at the European Society for Medical Oncology (@myESMO) Congress 2026, which will be held October 23–27 in Madrid, Spain. Read more: #ESMO26
    Download
    02110120.3K
  12. Moderna✓@moderna_tx
    With our partners at @Merck, we announced detailed results from the Phase 3 INTerpath-001 trial evaluating intismeran autogene (mRNA-4157 or V940), an investigational individualized neoantigen therapy, in combination with pembrolizumab, in patients with completely resected stage IIB-IV melanoma. Presented during a Presidential Symposium at the European Society for Medical Oncology (ESMO) Congress 2026, these findings offer important insights into the potential of individualized cancer treatment. Read more:
    Download
    01812826.1K
  13. Moderna✓@moderna_tx
    ANNOUNCEMENT 📢: We are proud to announce that the first participant has been dosed in the Phase 1 study of mRNA-1644, our experimental #HIV #mRNA #vaccine candidate. Learn more about this exciting venture with @IAVI:
    Download
    2826.3K18K
  14. Show more posts